Letolizumab (INN; development code BMS-986004) is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. This drug was developed by…
Letolizumab (INN; development code BMS-986004) is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.
This drug was developed by Bristol-Myers Squibb.Statement On A Nonproprietary Name Adopted By The USAN Council - Letolizumab, American Medical Association.
References
Gebaseerd op: Wikipedia — Letolizumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.